Document Detail


Blood pressure lowering, fibrinolysis enhancing and antioxidant activities of cardamom (Elettaria cardamomum).
MedLine Citation:
PMID:  20361714     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Elettaria cardamomum (L.) Maton. (Small cardamom) fruit powder was evaluated for its antihypertensive potential and its effect on some of the cardiovascular risk factors in individuals with stage 1 hypertension. Twenty, newly diagnosed individuals with primary hypertension of stage 1 were administered 3 g of cardamom powder in two divided doses for 12 weeks. Blood pressure was recorded initially and at 4 weeks interval for 3 months. Blood samples were also collected initially and at 4 weeks interval for estimation of lipid profile, fibrinogen and fibrinolysis. Total antioxidant status, however, was assessed initially and at the end of the study. Administration of 3 g cardamom powder significantly (p<0.001) decreased systolic, diastolic and mean blood pressure and significantly (p<0.05) increased fibrinolytic activity at the end of 12th week. Total antioxidant status was also significantly (p<0.05) increased by 90% at the end of 3 months. However, fibrinogen and lipid levels were not significantly altered. All study subjects experienced a feeling of well being without any side-effects. Thus, the present study demonstrates that small cardamom effectively reduces blood pressure, enhances fibrinolysis and improves antioxidant status, without significantly altering blood lipids and fibrinogen levels in stage 1 hypertensive individuals.
Authors:
S K Verma; Vartika Jain; S S Katewa
Related Documents :
10783044 - Ultrasonographic study of carotid artery structural changes with natural longevity.
21063874 - Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in...
17599024 - Long-term fish intake is associated with better lipid profile, arterial blood pressure,...
22310304 - Experimental assessment of the effects of gastrointestinal parasites on offspring quali...
1889494 - Comparison of the effects of intravenous almitrine and positive end-expiratory pressure...
3548474 - Severe acute anaemia in a jehovah's witness. survival without blood transfusion.
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Indian journal of biochemistry & biophysics     Volume:  46     ISSN:  0301-1208     ISO Abbreviation:  Indian J. Biochem. Biophys.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2010-04-05     Completed Date:  2010-10-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0310774     Medline TA:  Indian J Biochem Biophys     Country:  India    
Other Details:
Languages:  eng     Pagination:  503-6     Citation Subset:  IM    
Affiliation:
Indigenous Drug Research Center, Department of Medicine, RNT Medical College, Udaipur 313 001, Rajasthan, India. skvermaster@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antioxidants / pharmacology*
Blood Pressure / drug effects*
Elettaria*
Fibrinolysis / drug effects*
Humans
Hypertension / metabolism,  physiopathology
Lipid Metabolism / drug effects
Middle Aged
Single-Blind Method
Time Factors
Chemical
Reg. No./Substance:
0/Antioxidants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Therapeutic role of L-arginine on free radical scavenging system in ischemic heart diseases.
Next Document:  Hypolipidemic activity of Hibiscus rosa sinensis root in rats.